$700 Million is the total value of Foyston, Gordon, & Payne Inc's 76 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KO | Coca Cola Co. | $3,957,000 | -1.0% | 93,720 | 0.0% | 0.56% | -1.6% | |
| BRKB | Berkshire Hathaway Inc. CL B | $2,451,000 | +8.7% | 16,323 | 0.0% | 0.35% | +8.0% | |
| MDLZ | Mondelez International Inc. | $2,007,000 | +6.0% | 55,256 | 0.0% | 0.29% | +5.5% | |
| WMT | Wal-Mart Stores Inc. | $1,713,000 | +12.3% | 19,950 | 0.0% | 0.24% | +11.9% | |
| KRFT | Kraft Foods Group Inc. | $1,154,000 | +11.1% | 18,418 | 0.0% | 0.16% | +10.7% | |
| BDX | Becton Dickinson & Co. | $877,000 | +22.3% | 6,300 | 0.0% | 0.12% | +21.4% | |
| ABBV | AbbVie Inc. | $798,000 | +13.2% | 12,200 | 0.0% | 0.11% | +12.9% | |
| NVS | Novartis AG - ADR | $751,000 | -1.4% | 8,100 | 0.0% | 0.11% | -1.8% | |
| IVV | IShares S&P 500 Index Fund | $641,000 | +4.2% | 3,100 | 0.0% | 0.09% | +4.5% | |
| UTX | United Technologies Corp. | $596,000 | +8.8% | 5,185 | 0.0% | 0.08% | +7.6% | |
| ABT | Abbott Laboratories | $549,000 | +8.3% | 12,200 | 0.0% | 0.08% | +6.8% | |
| IBM | IBM | $502,000 | -15.3% | 3,126 | 0.0% | 0.07% | -15.3% | |
| JPM | JPMorgan Chase & Co. | $280,000 | +4.1% | 4,471 | 0.0% | 0.04% | +2.6% | |
| CMA | Comerica Inc. | $226,000 | -5.8% | 4,820 | 0.0% | 0.03% | -5.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corp. | 42 | Q3 2023 | 10.2% |
| Johnson & Johnson | 42 | Q3 2023 | 9.3% |
| Mondelez International Inc. | 42 | Q3 2023 | 4.0% |
| Coca Cola Co. | 42 | Q3 2023 | 1.7% |
| Berkshire Hathaway Inc. CL B | 42 | Q3 2023 | 1.6% |
| Becton Dickinson & Co. | 42 | Q3 2023 | 2.7% |
| Wal-Mart Stores Inc. | 42 | Q3 2023 | 0.9% |
| AbbVie Inc. | 42 | Q3 2023 | 0.5% |
| Abbott Laboratories | 42 | Q3 2023 | 0.4% |
| Procter & Gamble Co. | 42 | Q3 2023 | 0.2% |
View Foyston, Gordon, & Payne Inc's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Foyston, Gordon, & Payne Inc | September 20, 2012 | 4,798,387 | 4.8% |
| Foyston, Gordon, & Payne Inc | April 25, 2012 | 8,966,382 | 9.2% |
| TECUMSEH PRODUCTS CO | July 17, 2006 | 553,579 | 4.1% |
| CPI CORPSold out | April 27, 2006 | 0 | 0.0% |
View Foyston, Gordon, & Payne Inc's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-10-26 |
| 13F-HR | 2023-08-01 |
| 13F-HR | 2023-05-03 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-04 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-04-27 |
| 13F-HR | 2022-02-11 |
View Foyston, Gordon, & Payne Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.